Garenoxacin
- Level
- Commodity
- Parent
- 51282900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282920This classification denotes a quinolone antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V72H9867WB. European Medicines Agency schedules Garenoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25475. Garenoxacin generally arises in the molecular formula C23H20F2N2O4. The term GARENOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, no. 2, 2003, list 49.) Most nations schedule garenoxacin under HS 29334990 and SITC 51575. As of Q4 2014, GARENOXACIN remains the US FDA Preferred Term for this commodity. Garenoxacin bears US NLM identifiers UMLS ID C1507354 and NCI Concept Code C65800. SMILES: FC(F)OC1C2N(C3CC3)CC(C(=O)C2CCC1C1CC2C(C(NC2)C)CC1)C(=O)O.
Same parent
Under 51282900 · 57Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.